Qualigen Therapeutics Inc
NASDAQ:AIXC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Qualigen Therapeutics Inc
NASDAQ:AIXC
|
US |
|
Chemistree Technology Inc
F:CM1
|
CA |
|
R
|
Red Robin Gourmet Burgers Inc
F:RRN
|
US |
|
Ems Chemie Holding AG
F:EMC1
|
CH |
|
E
|
Experian PLC
F:J2B
|
IE |
|
G
|
Grenke AG
LSE:0R97
|
DE |
|
M
|
MSP Recovery Inc
NASDAQ:MSPR
|
US |
|
T
|
Trilogy Metals Inc
AMEX:TMQ
|
CA |
|
S
|
Solteq Oyj
OMXH:SOLTEQ
|
FI |
|
Hyundai Motor Co
F:HYU
|
KR |
|
H & R Block Inc
NYSE:HRB
|
US |
|
Industria de Diseno Textil SA
OTC:IDEXF
|
ES |
|
I
|
IDEXX Laboratories Inc
LSE:0J8P
|
US |
|
Curtis Banks Group PLC
LSE:CBP
|
UK |
|
S
|
Smartone Telecommunications Holdings Ltd
XMUN:SMA
|
HK |
|
C
|
Carrefour SA
DUS:CAR
|
FR |
|
A
|
AbraSilver Resource Corp
F:1AH0
|
CA |
|
P
|
PDS Biotechnology Corp
F:EU6
|
US |
|
P
|
Pfizer Inc
DUS:PFE
|
US |
|
Inventiva SA
PAR:IVA
|
FR |
Bankruptcy Probability
Qualigen Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Qualigen Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Qualigen Therapeutics Inc
NASDAQ:QLGN
|
4.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
465.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
209.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
164.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Qualigen Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Qualigen Therapeutics Inc has total debt of 3.6m USD. This includes both short-term (3.6m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
